Premium
FOTEMUSTINE‐BASED THERAPY IN COMBINATION WITH RITUXIMAB AS FIRST‐LINE INDUCTION CHEMOTHERAPY FOLLOWED BY WBRT FOR NEWLY DIAGNOSED PCNSL: A PROSPECTIVE PHASE II TRIAL
Author(s) -
Wu J,
Gao F,
Zhang L,
Li X,
Li L,
Sun Z,
Wang X,
Fu X,
Zhang X,
Zhang M
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.36_2881
Subject(s) - medicine , regimen , rituximab , neutropenia , dexamethasone , phases of clinical research , primary central nervous system lymphoma , chemotherapy regimen , chemotherapy , surgery , leukopenia , gastroenterology , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom